Exogenous nitric oxide regulates activity and synthesis of vascular endothelial nitric oxide synthase

European Journal of Clinical Investigation

Volumn 38, Issue 7, 2008, Pages 476-485

  Schmidt, A ^a   Bilgasem, S ^a   Lorkowski, S ^a   Vischer, P ^a   Volker W ^a   Breithardt, G ^a,b   Siegel, G ^c   Buddecke, E ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cell culture; Endothelial dysfunction; Endothelial nitric oxide synthase; Synthetic NO donors

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ARGININE; CELL PROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE DONOR; PROTEIN KINASE B; SERINE; VASCULOTROPIN;

ARTICLE; CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL VOLUME; CLINICAL STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME SYNTHESIS; HALF LIFE TIME; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; MODELS, BIOLOGICAL; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE TYPE III; SIGNAL TRANSDUCTION; STATISTICS AS TOPIC; TRIAZENES;

EID: 45149118566     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2008.01967.x     Document Type: Article

References (38)

1. Lloyd-Jones IM, Block KD. The vascular biology of nitric oxide and its role in atherogenesis. Annu Rev Med 1996 47 : 365 75.
2. Mallis RJ, Buss JE, Thomas JA. Oxidative modification of H-ras: S-thiolation and S-nitrosylation of reactive cysteines. Biochem J 2001 355 : 145 53.
3. Castel H, Vaudry H. Nitric oxide directly activates GABA (A) receptor function through a cGMP/protein kinase-independent pathway in frog pituitary melanotrophs. J Neuroendocrinol 2001 13 : 695 705.
4. Sun J, Xin C, Eu JP, Stamler JS, Meissner G. Cysteine-3635 is responsible for skeletal muscle ryanodine receptor modulation by NO. Proc Natl Acad Sci USA 2001 98 : 1158 62.
5. Clancy RM, Leszczynska P, Piziak J, Abramson SB. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on NADPH oxidase. J Clin Invest 1992 90 : 1116 21.
6. Herman AG, Moncada S. Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis. Eur Heart J 2005 26 : 1945 55.
7. Münzel T, Daiber A, Ullrich V, Mülsch A. Vascular Consequences of Endothelial Nitric Oxide Synthase Uncoupling for the Activity and Expression of the Soluble Guanyl Cyclase and the cGMP-Dependent Protein Kinase. Arterioscler Thromb Vasc Biol 2005 25 : 1551 75.
8. Drexler H, Zeiher AM, Wollschläger H, Meinertz T, Just H, Bonzel T. Flow-dependent coronary artery dilatation in humans. Circulation 1989 80 : 466 74.
9. Vogel RA. Brachial artery ultrasound: a noninvasive tool in the assessment of triglyceride-rich lipoproteins. Clin Cardiol 1999 22 (Suppl. 6 II34 9.
10. Lefer DJ, Lefer AM. Studies on the mechanism of the vasodilator action of nicorandil. Life Sci 1988 42 : 1907 14.
11. Yamamoto T, Bing RJ. Nitric oxide donors. Proc Soc Exp Biol Med 2000 225 : 200 6.
12. Förstermann U, Münzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 2006 113 : 1708 14.
13. Münzel T, Daiber A, Mülsch A. Explaining the Phenomenon of Nitrate Tolerance. Circ Res 2005 97 : 618 28.
14. 1 and overproduction of extracellular matrix in human coronary smooth muscle cells. Cardiovasc Res 2003 58 : 671 8.
15. Young DV, Serebryanik D, Janero DR, Tam SW. Suppression of proliferation of human coronary artery smooth muscle cells by the nitric oxide donor, S-nitrosoglutathione, is cGMP-independent. Mol Cell Biol Res Commun 2000 4 : 32 6.
16. Sarkar R, Gordon D, Stanley JC, Webb RC. Cell cycle effects of nitric oxide on vascular smooth muscle cells. Am J Physiol 1997 272 : H1810 8.
17. Mooradian DL, Hutsell TC, Keefer LK. Nitric oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vitro. J Cardiovasc Pharmacol 1995 25 : 674 8.
18. Hrabie JA, Klose JR, Wink DA, Keefer LK. New nitric oxide-releasing zwitterions derived from polyamines. J Org Chem 1993 58 : 1472 6.
19. Keefer LK, Nims RW, Davies KM, Wink DA. 'NONOates' (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Meth Enzymol 1996 268 : 281 93.
20. Ishimaru RS, Leung K, Hong L, LaPolt PS. Inhibitory effects of nitric oxide on estrogen production and cAMP levels in rat granulosa cell cultures. J Endocrinol 2001 168 : 249 55.
21. Boyle JJ, Weissberg PL, Bennett MR. Human macrophage-induced vascular smooth muscle cell apoptosis requires NO enhancement of Fas/Fas-L interactions. Arterioscler Thromb Vasc Biol 2002 22 : 1624 30.
22. Schmidt A, Goepfert C, Feitsma K, Buddecke E. Lovastatin-stimulated superinduction of E-selectin, ICAM-1 and VCAM-1 in TNF-α activated human vascular endothelial cells. Atherosclerosis 2002 164 : 57 64.
23. Schmidt A, Vlodavsky I, Völker W, Buddecke E. Differentiation of coronary smooth muscle cells to a cell cycle-arrested hypertrophic growth status by a synthetic non-toxic heparin-mimicking compound. Atherosclerosis 1999 147 : 387 97.
24. Stolle K, Weitkamp B, Rauterberg J, Lorkowski S, Cullen P. Laser microdissection-based analysis of mRNA expression in human coronary arteries with intimal thickening. J Histochem Cytochem 2004 52 : 1511 8.
25. Schmidt A, Lorkowski S, Seidler D, Breithardt G, Buddecke E. TGF-beta1 generates a specific multicomponent extracellular matrix in human coronary SMC. Eur J Clin Invest 2006 36 : 473 82.
26. Fleming I, Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 2003 284 : R1 R12.
27. Fukuchi M, Hussain SNA, Giaid A. Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in endstage human heart failure. Their relation to lesion site and β-adrenergic receptor therapy. Circulation 1998 98 : 132 9.
28. Shah AM. Inducible nitric oxide synthase and cardiovascular disease. Cardiovasc Res 2000 45 : 148 55.
29. Gélinas DS, Bernatchez PN, Rollin S, Bazan NG, Sirois MG. Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: Role of PI3K, PKC and PLC pathways. Br J Pharmacol 2002 137 : 1021 30.
30. Schulz R, Schmidt D, Blum A, Lopes-Ribeiro X, Lücke C, Mayer K et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax 2000 55 : 1046 51.
31. Santoni Y, Iliadis A, Cano J-P, Luccioni R, Frances Y. Pharmacokinetics of Isosorbide Dinitrate and Its Mononitrate Metabolites After Intravenous Infusion. J Pharmacokin Biopharm 1986 14 : 1 17.
32. Ignarro LJ, Napoli C, Loscalzo J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide. An overview. Circ Res 2002 90 : 21 8.
33. Fisslthaler B, Fleming I, Keserü B, Walsh K, Busse R. Fluid Shear Stress and NO Decrease the Activity of the Hydroxy-Methylglutaryl Coenzyme A Reductase in Endothelial Cells via the AMP-Activated Protein Kinase and FoxO1. Circ Res 2007 : 100 : e12 e21.
34. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995 345 : 669 85.
35. Ishikawa K, Kanamasa K, Ogawa I, Takenaka T, Naito T, Kamata N et al. Long-term nitrate treatment increases cardiac events in patients with healed myocardial infarction. Secondary Prevention Group. Jpn Circ J 1996 60 : 779 88.
36. Nakamura Y, Moss AJ, Brown MW, Kinoshita M, Kawai C. Long-term nitrate use may be deleterious in ischemic heart disease: a study using the databases from two large-scale postinfarction studies. Multicenter Myocardial Ischemia Research Group. Am Heart J 1999 138 : 577 85.
37. Thomas GR, DiFabio JM, Gori T, Parker JD. Once daily Therapy With Isosorbide-5-Mononitrate Causes Endothelial Dysfunction in Humans. J Am Coll Cardiol 2007 49 : 1289 95.
38. Lablanche JM, Grollier G, Lusson JR, Bassand JP, Drobinski G, Bertrand B et al. Effect of the direct nitric oxide donors linsidomine and molsidomine on angiographic restenosis after coronary balloon angioplasty. The ACCORD Study. Angioplastic Coronaire Corvasal Diltiazem. Circulation 1997 95 : 83 9.